Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma.
Saved in:
| Title: | Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma. |
|---|---|
| Authors: | Nishimura, Tadashi1,2 (AUTHOR), Fujiwara, Takumi2,3 (AUTHOR), Fujimoto, Hajime2 (AUTHOR), Tarumi, Hirotoshi1 (AUTHOR), Tsuji, Chikashi1 (AUTHOR), Iwanaka, Soichi1 (AUTHOR), Sakakura, Yasumasa1 (AUTHOR), Naito, Masahiro1 (AUTHOR), Okugawa, Yoshinaga3 (AUTHOR), Yasuma, Taro4 (AUTHOR), Gabazza, Esteban Cesar4 (AUTHOR) gabazza@doc.medic.mie-u.ac.jp, Oomoto, Yasuhiro1 (AUTHOR), Kobayashi, Tetsu2 (AUTHOR), Ibata, Hidenori1 (AUTHOR) |
| Source: | Thoracic Cancer. Mar2023, Vol. 14 Issue 7, p709-713. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
